Company intelligence / Profile preview

Chesapeake Urology Research Associates

Baltimore, Maryland, United States

Ownership: Private
Employees: ~850
Development stage: Other

Overview

Chesapeake Urology’s research division, also known as Chesapeake Urology Research Associates (CURA), conducts clinical trials in partnership with academic and industry collaborators, with an emphasis on prostate cancer and other urologic conditions. Current clinical trials include advanced diagnostics for prostate cancer and investigational therapies for bladder and renal cell cancers. Final trial results are not publicly available, but the center offers access to investigational therapies before public approval.

Therapeutic areas: OncologyMen's Health
Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Partnerships

American Urological AssociationUrology Care Foundation

Beyond the preview

Go deeper on Chesapeake Urology Research Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chesapeake Urology Research Associates.

Explore the full profile